Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Annals of Medicine|November 14, 2025
The lactate-lactylation axis in renal fibrosis: potential mechanisms in diabetic kidney diseaseXuejiao Wei, Mengtuan Long, Jiayuan Yu, et al.Life Sciences|October 21, 2022
Advances in energy metabolism in renal fibrosisXuejiao Wei, Yue Hou, Mengtuan Long, et al.Frontiers in Endocrinology|August 12, 2022
Molecular mechanisms underlying the role of hypoxia-inducible factor-1 α in metabolic reprogramming in renal fibrosisXuejiao Wei, Yue Hou, Mengtuan Long, et al.Nephrology (Carlton, Vic.)|May 29, 2021
Recent research progress on the role of ulinastatin in chronic kidney diseaseXuejiao Wei, Xiaoyu Zhu, Lili Jiang, et al.Frontiers in Pharmacology|September 15, 2022
Roxadustat: Not just for anemiaXiaoyu Zhu, Lili Jiang, Xuejiao Wei, et al.Scientific Reports|November 14, 2024
Ulinastatin attenuates renal fibrosis by regulating AMPK/HIF-1α signaling pathway-mediated glycolysisXuejiao Wei, Mengtuan Long, Zhongyu Fan, et al.Frontiers in Medicine|December 3, 2021
Metabolic Reprogramming and Renal FibrosisXiaoyu Zhu, Lili Jiang, Mengtuan Long, et al.Frontiers in Endocrinology|March 25, 2024
Prediction of immunotherapy response in idiopathic membranous nephropathy using deep learning-pathological and clinical factorsXuejiao Wei, Mengtuan Long, Zhongyu Fan, et al.Frontiers in Endocrinology|April 18, 2024
Whole-body water mass and kidney function: a Mendelian randomization studyXuejiao Wei, Mengtuan Long, Zhongyu Fan, et al.Renal Failure|May 26, 2022
Pro- and anti-fibrotic effects of vascular endothelial growth factor in chronic kidney diseasesChangxiu Miao, Xiaoyu Zhu, Xuejiao Wei, et al.Pageof 2